-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Focus on Chemical Machinery Equipment Network ] In recent years, with the rapid development of China's pharmaceutical industry, especially the rise of innovative drugs, the variety of pharmaceutical companies has continued to increase, and the innovative strength of many companies has been improved, and they have begun to expand into the international market.
The implementation of the Sino-US dual reporting system for many types of drugs puts forward higher requirements on the automation and intelligence level of pharmaceutical equipment
.
In addition, the policy also supports the development of high-end pharmaceutical equipment.
With the promotion of strategic deployments such as "Made in China 2025", China's pharmaceutical equipment industry has ushered in new opportunities and accelerated its transformation and upgrading towards automation and intelligence
.
On the whole, the upgrading and transformation process of China's pharmaceutical equipment industry is accelerating
.
Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipmentThe implementation of the Sino-US dual reporting system for many types of drugs puts forward higher requirements on the automation and intelligence level of pharmaceutical equipment
.
In addition, the policy also supports the development of high-end pharmaceutical equipment.
With the promotion of strategic deployments such as "Made in China 2025", China's pharmaceutical equipment industry has ushered in new opportunities and accelerated its transformation and upgrading towards automation and intelligence
.
On the whole, the upgrading and transformation process of China's pharmaceutical equipment industry is accelerating
.
At present, China's pharmaceutical equipment industry has entered a stage of stable development
.
The data shows that the asset scale of the pharmaceutical special equipment industry has increased from 20.
7 billion yuan in February 2019 to 30.
2 billion yuan at the end of 2020, an increase of 45.
67%
.
The overall sales of the industry also performed well.
In 2020, the total revenue of the pharmaceutical special equipment manufacturing industry was 19.
7 billion yuan, a year-on-year increase of 14.
6%
.
.
The data shows that the asset scale of the pharmaceutical special equipment industry has increased from 20.
7 billion yuan in February 2019 to 30.
2 billion yuan at the end of 2020, an increase of 45.
67%
.
The overall sales of the industry also performed well.
In 2020, the total revenue of the pharmaceutical special equipment manufacturing industry was 19.
7 billion yuan, a year-on-year increase of 14.
6%
.
From the perspective of the industry competition pattern, in the past, the market participants of the entire pharmaceutical equipment industry in China were mostly small and medium-sized enterprises, the competition was relatively scattered, and most of them were price wars.
In recent years, the market demand has become more diverse and the requirements have become increasingly strict Next, the business of pharmaceutical giants represented by Chutian Technology and Dongfulong has begun to develop in a more diversified direction, and the competitive landscape of the pharmaceutical equipment industry is improving
.
In recent years, the market demand has become more diverse and the requirements have become increasingly strict Next, the business of pharmaceutical giants represented by Chutian Technology and Dongfulong has begun to develop in a more diversified direction, and the competitive landscape of the pharmaceutical equipment industry is improving
.
Take Tofflon as an example.
In the early days, the company was mainly engaged in the research and development, production and sales of freeze-drying equipment, and then continued to extend vertically to the industry, to freeze-drying systems, with washing and drying irrigation systems, drug weighing and preparation filtration systems, and light inspections.
Equipment, rubber stopper cleaning machine , capping machine and other auxiliary equipment ; then the freeze-drying unit is integrated with the process manufacturing equipment, water system, HVAC system, and automation control system to become a freeze-drying project, realizing the completion of freeze-drying through preset parameters Automated production of products
.
At the same time, the company deeply implements a systematic and international development strategy, and is moving towards a more automated and intelligent overall solution
.
Washing machine auxiliary equipmentIn the early days, the company was mainly engaged in the research and development, production and sales of freeze-drying equipment, and then continued to extend vertically to the industry, to freeze-drying systems, with washing and drying irrigation systems, drug weighing and preparation filtration systems, and light inspections.
Equipment, rubber stopper cleaning machine , capping machine and other auxiliary equipment ; then the freeze-drying unit is integrated with the process manufacturing equipment, water system, HVAC system, and automation control system to become a freeze-drying project, realizing the completion of freeze-drying through preset parameters Automated production of products
.
At the same time, the company deeply implements a systematic and international development strategy, and is moving towards a more automated and intelligent overall solution
.
The main business of Chutian Technology was the manufacturing and sales of medical equipment in the early days of its establishment.
Early income was mainly from liquid pharmaceutical equipment.
However, in 2016, when the industry experienced a cliff-like decline and the company’s traditional business fell sharply, Chutian Technology started Extensional mergers and acquisitions have continuously strengthened their competitive advantages.
For example, by increasing capital and holding Longleavy (Beijing), the company has further expanded the company's product areas, from liquid pharmaceutical equipment to the solid preparation market
.
In 2020, as Romaco merges into its listed company as a whole, the synergy between the two parties will gradually appear, and the business sector will be supplemented and strengthened.
Chutian Technology will also use Romaco to achieve an international layout and increase the company's market share
.
At present, Chutian Technology is an enterprise in the industry that possesses both the overall solution of liquid formulations and the overall solution of solid formulations
.
Early income was mainly from liquid pharmaceutical equipment.
However, in 2016, when the industry experienced a cliff-like decline and the company’s traditional business fell sharply, Chutian Technology started Extensional mergers and acquisitions have continuously strengthened their competitive advantages.
For example, by increasing capital and holding Longleavy (Beijing), the company has further expanded the company's product areas, from liquid pharmaceutical equipment to the solid preparation market
.
In 2020, as Romaco merges into its listed company as a whole, the synergy between the two parties will gradually appear, and the business sector will be supplemented and strengthened.
Chutian Technology will also use Romaco to achieve an international layout and increase the company's market share
.
At present, Chutian Technology is an enterprise in the industry that possesses both the overall solution of liquid formulations and the overall solution of solid formulations
.
Another example is Canaan Technology.
The company is mainly engaged in the manufacture of special pharmaceutical equipment.
After the listing, the company has rapidly deployed the fluid equipment and powder equipment industries around the health industry according to the "one body and two wings" strategy, completing the development from stand-alone equipment to overall comprehensive solutions.
.
At present, the company can provide pharmaceutical companies with specialized, customized, integrated, and intelligent solid preparation smart factory whole-line equipment and supporting process design solutions, with process design capabilities and core equipment R&D and manufacturing capabilities
.
In September 2020, the company also strengthened its main business layout through a fixed increase of 450 million yuan, providing important support for the company to achieve its development goal of strategic transformation into a modern intelligent manufacturing enterprise
.
The company is mainly engaged in the manufacture of special pharmaceutical equipment.
After the listing, the company has rapidly deployed the fluid equipment and powder equipment industries around the health industry according to the "one body and two wings" strategy, completing the development from stand-alone equipment to overall comprehensive solutions.
.
At present, the company can provide pharmaceutical companies with specialized, customized, integrated, and intelligent solid preparation smart factory whole-line equipment and supporting process design solutions, with process design capabilities and core equipment R&D and manufacturing capabilities
.
In September 2020, the company also strengthened its main business layout through a fixed increase of 450 million yuan, providing important support for the company to achieve its development goal of strategic transformation into a modern intelligent manufacturing enterprise
.
Generally speaking, in the process of accelerating the upgrading and transformation of the domestic pharmaceutical equipment industry, compared with small and medium-sized enterprises, domestic pharmaceutical machinery giants have more advantages in capital, technology, resources, etc.
, and have stronger R&D capabilities and diversified businesses.
It is expected to be a new growth in its performance
.
With the advent of a new round of development opportunities in the pharmaceutical equipment industry, domestic pharmaceutical machinery giants will win the opportunity, and some small and medium-sized enterprises that do not have the ability to adapt to the upgrading and transformation of the industry may withdraw from the market
.
, and have stronger R&D capabilities and diversified businesses.
It is expected to be a new growth in its performance
.
With the advent of a new round of development opportunities in the pharmaceutical equipment industry, domestic pharmaceutical machinery giants will win the opportunity, and some small and medium-sized enterprises that do not have the ability to adapt to the upgrading and transformation of the industry may withdraw from the market
.
Original title: The upgrading and transformation process of domestic pharmaceutical equipment industry is accelerating, and the competitive landscape is improving
